论文部分内容阅读
近年来,部分重特大(罕见)疾病患者因为其必须使用的靶向药、高价药在医保目录之外,无法报销,导致生活困难。为完善大病保险制度,提高基金使用效率,减轻重特大疾病患者医药费用负担,缓解因病致贫、因病返贫等问题,江西省通过建立专家评审、价格谈判、契约管理等机制,2015年1月1日起将甲磺酸伊马替尼等5种医保目录外的特殊药品纳入大病保险基金支付范
In recent years, in some patients with extremely large (rare) diseases because of the targeted drugs they must use, high-priced medicines can not be reimbursed outside the medical insurance catalogs, resulting in difficulties in living. In order to improve the system of serious illness insurance, improve the efficiency of fund utilization, reduce the burden of medical expenses on patients with major and serious diseases, and alleviate the problems of poverty caused by illness and return to poverty due to illness, Jiangxi Province, through establishing mechanisms such as expert review, price negotiation and contract management, On the 1st of January, imatinib mesylate and other five kinds of medical insurance will be included in the list of special medicines to pay insurance costs